Weight Loss Jabs Prescribed Through Healthcare Services: What to Know

Prescription injectable weight management medicines belong to a class called GLP-1 receptor agonists. Semaglutide acts on GLP-1 receptors to reduce appetite and increase feelings of fullness, while tirzepatide acts on both GLP-1 and GIP receptors. Both are taken as a once-weekly subcutaneous injection using a pre-filled pen.

How access works

Whether through a publicly funded service, a specialist weight management clinic, or a private prescriber, the route to these medicines always begins with a qualified prescriber assessing your suitability. In some countries and regions — including parts of Scotland and England — certain injectable weight management medicines have been made available through commissioned healthcare programmes, but eligibility criteria, availability, and rollout timescales vary considerably depending on where you live and the service you are referred to. Your prescriber or doctor is the right person to advise on what is available to you locally.

If you are researching what the weight loss jab involves as a treatment, it is worth understanding that these are prescription-only medicines — they are not available over the counter, and suitability is always decided on an individual basis by a clinician.

Injection sites and rotation

Once prescribed, these medicines are self-injected under the skin. The three commonly used sites are the abdomen, the front of the thigh, and the upper arm. Rotating between sites is generally recommended to allow each area to recover and to reduce the chance of injection-site reactions such as localised redness or swelling.

Your prescriber or the patient information leaflet that came with your pen will give you specific guidance on technique. If you notice persistent reactions at any site, or have questions about where to inject, raise them with your healthcare professional.

Supply disruptions have affected some users at various points — if you are concerned about continuity of supply, see our page on managing a weight loss jab shortage for general guidance, and speak to your prescriber or pharmacist. For information specific to tirzepatide, our guide to Mounjaro as a weight loss jab covers the key facts.

Keeping track of a weekly injection schedule — including which site you used last, what dose you are on, and when your next injection is due — is surprisingly easy to lose track of over weeks and months. GLP Trackr is designed specifically to remove that friction.

Injection-site rotation, made automatic

Each time you log an injection in the app, you record the site you used — abdomen, thigh, or upper arm — along with the date, time, and dose strength. GLP Trackr uses that history to suggest your next rotation site, so you are never guessing where you injected three weeks ago. Gentle dose reminders mean a weekly injection is far less likely to slip your mind.

A record you can bring to appointments

The app also lets you log any injection-site reactions or other side effects as you notice them, building a timeline you can share with your prescriber. Rather than trying to recall how things have felt over several weeks, you arrive at your next appointment with a clear picture already in hand. Our broader guide to weight loss injections covers more about managing your injectable treatment over the long term.

If any injection-site reaction is severe, spreading, or does not resolve, contact your healthcare professional promptly — the app supports your tracking, but it is not a substitute for clinical advice. Any concerns about your dose, injection technique, or side effects should always be discussed with your prescriber or doctor.

Ready to take the guesswork out of your weekly injection routine? Download GLP Trackr on the App Store or Google Play and get started with a free 7-day trial.